Cargando…

Patient and Physician Perspectives in the Management of Immune Thrombocytopenia in Iran: Responses from the ITP World Impact Survey (I-WISh)

Data describing physicians’ and patients’ perspectives towards immune thrombocytopenia (ITP) management and impact of disease in Iran are limited. This ITP World Impact Survey was conducted between October 2019 and October 2020. Of the 114 patients included in the survey, 17 were aged ≤18 years. For...

Descripción completa

Detalles Bibliográficos
Autores principales: Eshghi, Peyman, Abolghasemi, Hassan, Akhlaghi, Ali A., Ashrafi, Farzaneh, Bordbar, Mohammadreza, Hajifathali, Abbas, Hosseini, Hamed, Mirbehbahani, Nargesbeigom, Abedini, Ayat, Shahsavarani, Narges, Faranoush, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841860/
https://www.ncbi.nlm.nih.gov/pubmed/36630731
http://dx.doi.org/10.1177/10760296221130335
_version_ 1784869988281090048
author Eshghi, Peyman
Abolghasemi, Hassan
Akhlaghi, Ali A.
Ashrafi, Farzaneh
Bordbar, Mohammadreza
Hajifathali, Abbas
Hosseini, Hamed
Mirbehbahani, Nargesbeigom
Abedini, Ayat
Shahsavarani, Narges
Faranoush, Mohammad
author_facet Eshghi, Peyman
Abolghasemi, Hassan
Akhlaghi, Ali A.
Ashrafi, Farzaneh
Bordbar, Mohammadreza
Hajifathali, Abbas
Hosseini, Hamed
Mirbehbahani, Nargesbeigom
Abedini, Ayat
Shahsavarani, Narges
Faranoush, Mohammad
author_sort Eshghi, Peyman
collection PubMed
description Data describing physicians’ and patients’ perspectives towards immune thrombocytopenia (ITP) management and impact of disease in Iran are limited. This ITP World Impact Survey was conducted between October 2019 and October 2020. Of the 114 patients included in the survey, 17 were aged ≤18 years. Forty-seven physicians, including 22 pediatric hematologists, participated in the survey. Fatigue and anxiety around stable platelet counts were frequent patient-reported symptoms at diagnosis and at survey completion. According to physicians, “watch-and-wait” was the preferred treatment option for mean (standard deviation) proportion of 50.1 (24.1) and 48.6 (21.8) of their adult and pediatric patients, respectively, following first diagnosis. Per adult and pediatric hematologists, the most prescribed treatments for newly diagnosed patients based on available answers were steroids (100%, n = 20/20; 89%, n = 16/18), respectively. Forty percent of adult (n = 10/25) and 38% of pediatric hematologists (n = 8/21) reported that ITP reduced patients’ quality of life. Energy levels (46%, n = 52/112) and ability to concentrate on everyday activities (42%, n = 47/113) were the most affected aspects of patients' lives. This I-WISh study in Iran underlined the negative impact of ITP on patients.
format Online
Article
Text
id pubmed-9841860
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-98418602023-01-17 Patient and Physician Perspectives in the Management of Immune Thrombocytopenia in Iran: Responses from the ITP World Impact Survey (I-WISh) Eshghi, Peyman Abolghasemi, Hassan Akhlaghi, Ali A. Ashrafi, Farzaneh Bordbar, Mohammadreza Hajifathali, Abbas Hosseini, Hamed Mirbehbahani, Nargesbeigom Abedini, Ayat Shahsavarani, Narges Faranoush, Mohammad Clin Appl Thromb Hemost Original Manuscript Data describing physicians’ and patients’ perspectives towards immune thrombocytopenia (ITP) management and impact of disease in Iran are limited. This ITP World Impact Survey was conducted between October 2019 and October 2020. Of the 114 patients included in the survey, 17 were aged ≤18 years. Forty-seven physicians, including 22 pediatric hematologists, participated in the survey. Fatigue and anxiety around stable platelet counts were frequent patient-reported symptoms at diagnosis and at survey completion. According to physicians, “watch-and-wait” was the preferred treatment option for mean (standard deviation) proportion of 50.1 (24.1) and 48.6 (21.8) of their adult and pediatric patients, respectively, following first diagnosis. Per adult and pediatric hematologists, the most prescribed treatments for newly diagnosed patients based on available answers were steroids (100%, n = 20/20; 89%, n = 16/18), respectively. Forty percent of adult (n = 10/25) and 38% of pediatric hematologists (n = 8/21) reported that ITP reduced patients’ quality of life. Energy levels (46%, n = 52/112) and ability to concentrate on everyday activities (42%, n = 47/113) were the most affected aspects of patients' lives. This I-WISh study in Iran underlined the negative impact of ITP on patients. SAGE Publications 2023-01-11 /pmc/articles/PMC9841860/ /pubmed/36630731 http://dx.doi.org/10.1177/10760296221130335 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Manuscript
Eshghi, Peyman
Abolghasemi, Hassan
Akhlaghi, Ali A.
Ashrafi, Farzaneh
Bordbar, Mohammadreza
Hajifathali, Abbas
Hosseini, Hamed
Mirbehbahani, Nargesbeigom
Abedini, Ayat
Shahsavarani, Narges
Faranoush, Mohammad
Patient and Physician Perspectives in the Management of Immune Thrombocytopenia in Iran: Responses from the ITP World Impact Survey (I-WISh)
title Patient and Physician Perspectives in the Management of Immune Thrombocytopenia in Iran: Responses from the ITP World Impact Survey (I-WISh)
title_full Patient and Physician Perspectives in the Management of Immune Thrombocytopenia in Iran: Responses from the ITP World Impact Survey (I-WISh)
title_fullStr Patient and Physician Perspectives in the Management of Immune Thrombocytopenia in Iran: Responses from the ITP World Impact Survey (I-WISh)
title_full_unstemmed Patient and Physician Perspectives in the Management of Immune Thrombocytopenia in Iran: Responses from the ITP World Impact Survey (I-WISh)
title_short Patient and Physician Perspectives in the Management of Immune Thrombocytopenia in Iran: Responses from the ITP World Impact Survey (I-WISh)
title_sort patient and physician perspectives in the management of immune thrombocytopenia in iran: responses from the itp world impact survey (i-wish)
topic Original Manuscript
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841860/
https://www.ncbi.nlm.nih.gov/pubmed/36630731
http://dx.doi.org/10.1177/10760296221130335
work_keys_str_mv AT eshghipeyman patientandphysicianperspectivesinthemanagementofimmunethrombocytopeniainiranresponsesfromtheitpworldimpactsurveyiwish
AT abolghasemihassan patientandphysicianperspectivesinthemanagementofimmunethrombocytopeniainiranresponsesfromtheitpworldimpactsurveyiwish
AT akhlaghialia patientandphysicianperspectivesinthemanagementofimmunethrombocytopeniainiranresponsesfromtheitpworldimpactsurveyiwish
AT ashrafifarzaneh patientandphysicianperspectivesinthemanagementofimmunethrombocytopeniainiranresponsesfromtheitpworldimpactsurveyiwish
AT bordbarmohammadreza patientandphysicianperspectivesinthemanagementofimmunethrombocytopeniainiranresponsesfromtheitpworldimpactsurveyiwish
AT hajifathaliabbas patientandphysicianperspectivesinthemanagementofimmunethrombocytopeniainiranresponsesfromtheitpworldimpactsurveyiwish
AT hosseinihamed patientandphysicianperspectivesinthemanagementofimmunethrombocytopeniainiranresponsesfromtheitpworldimpactsurveyiwish
AT mirbehbahaninargesbeigom patientandphysicianperspectivesinthemanagementofimmunethrombocytopeniainiranresponsesfromtheitpworldimpactsurveyiwish
AT abediniayat patientandphysicianperspectivesinthemanagementofimmunethrombocytopeniainiranresponsesfromtheitpworldimpactsurveyiwish
AT shahsavaraninarges patientandphysicianperspectivesinthemanagementofimmunethrombocytopeniainiranresponsesfromtheitpworldimpactsurveyiwish
AT faranoushmohammad patientandphysicianperspectivesinthemanagementofimmunethrombocytopeniainiranresponsesfromtheitpworldimpactsurveyiwish